wp pharma labs semaglutide GLP-1s for weight management: Considerations for HR leaders Semaglutide Weight Loss Program |

,

GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro) work partly by slowing gastric emptying the rate at which your stomach empties its contents into the small intestine

Spotlight on Key Peptides The GutImmune Connection Safety, Legality, and Ethical Considerations Integrative Approach: Lifestyle and Other Therapies Hope or Hype

Sometimes things work for a while, then plateau

CagriSema Falls Further in Late-Stage Trial, But There Is a Caveat To make matters worse, on March 10, 2025, Novo Nordisk reported its CagriSema Phase 3 REDEFINE 2 CagriSema late-stage study revealed just 13.7% weight loss versus 3.1% placebo in overweight type 2 diabetes patients over a 68-week period, which was short of its 15% or higher expectations

CEO Reitano said on X that the pricing could make treatment cheaper than purchasing the same medications through retail pharmacies such as CVS Health